The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Abstract
Two thousand three hundred and thirty two nonselected brains from 1- to 100-year-old individuals were examined using immunocytochemistry (AT8) and Gallyas silver staining for abnormal tau; immunocytochemistry (4G8) and Campbell-Switzer staining were used for the detection ofβ-amyloid. A total of 342 cases was negative in the Gallyas stain but when restaged for AT8 only 10 were immunonegative. Fifty-eight cases had subcortical tau predominantly in the locus coeruleus, but there was no abnormal cortical tau (subcortical Stages a-c). Cortical involvement (abnormal tau in neurites) was identified first in the transentorhinal region (Stage 1a, 38 cases). Transentorhinal pyramidal cells displayed pretangle material (Stage 1b, 236 cases). Pretangles gradually became argyrophilic neurofibrillary tangles (NFTs) that progressed in parallel with NFT Stages I to VI. Pretangles restricted to subcortical sites were seen chiefly at younger ages. Of the total cases, 1,031 (44.2%) had β-amyloid plaques. The first plaques occurred in the neocortex after the onset of tauopathy in the brainstem. Plaques generally developed in the 40s in 4% of all cases, culminating in their tenth decade (75%). β-amyloid plaques and NFTs were significantly correlated (p < 0.0001). These data suggest that tauopathy associated with sporadic Alzheimer disease may begin earlier than previously thought and possibly in the lower brainstem rather than in the transentorhinal region.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Up to 60% of CU individuals over age 80 years have AD neuropathologic changes at autopsy or by biomarkers [60,152,212–214].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [213]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“screening revealed low rates of Braak 1–2 NFT stages in all three groups (Table 2), consistent with literature-based norms [3].”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It should be noted that tau aggregation in the brain is associated with older age and is generally uncommon in healthy young adults (Braak et al., 2011; Crary et al., 2014).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Braak et al., 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It is expected that many persons die with brains that exhibit AD neuropathologic change in the preclinical phase of AD; indeed, data support the modeled expectations (44, 142).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“Medial temporal and brainstem neurofibrillary changes were observed in our older TSC subjects, as expected, but at a rate comparable to that observed in the epilepsy and non-neurological control groups and age-based norms [3].”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [3]
In the citing paper
“In individuals with autosomal dominant mutations in genes coding for amyloid precursor protein (APP) or Presenilin 119 , alterations in Aβ generation that result in early deposition of plaque initiate the disease and patients invariably develop the full spectrum of tau pathology 120,121 .”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [121]
In the citing paper
“NFTs first appear in layer II of the entorhinal cortex (EC) during AD onset.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [231]
In the citing paper
“NFTs subsequently appear in interconnected anatomical regions within the brain, including the hippocampus and neocortex during neurodegenerative progression [229–231].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [231]
In the citing paper
“Furthermore, it impairs adult hippocampal neurogenesis in mice and affects cortical thickness, brain activity, and mitochondrial function well before significant Aβ accumulation in the human brains [74–76].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [76]
In the citing paper
“Most of all, this binary threshold does not reflect the reality of amyloid β and tau pathology, which is continuous and present at a minimal extent in almost all people older than 70 years,17 with important discrepancies between pathology burden and clinical symptoms at intermediate extents (panel 2).”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [17]
In the citing paper
“For tau biomarkers, there is also a strong discrepancy between neuropathological identification (in post-mortem studies, the presence of tau Braak stages I–II is almost universal after age 70 years)17,19 and in-vivo measures of tau aggregates on PET (36% of individuals are tau positive after the age of 70 years23).”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [17]
In the citing paper
“The concordance of genetics and Aβ deposition is aligned with CPC studies that indicate that AβPs may be a temporally “upstream” feature of the neocortical disease, with the caveats that brainstem and medial temporal lobe pretangles and NFTs are seen in subjects without Aβ deposition in all age categories (33, 39, 44).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“In contrast to NFTs, AβPs are extracellular (45, 46) and are found in a high proportion of all elderly persons but are not universal (44, 47, 48).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“Recently, it has been reported that NFTs are also very common in certain brainstem nuclei in subjects without dementia (39-44).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“Neurofibrillary pathology is observed in the human brain long before Aβ plaques develop (39, 44, 300).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“Neuritic plaques seem to develop after diffuse AβPs and NFTs (44).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
In the citing paper
“At 40 years, all individuals studied by Braak and Del Tredici (39) and Braak et al (44) exhibited at least initial neurofibrillary pathology in the brainstem (Fig. 5).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“The first lesions were usually seen in the transentorhinal region (2).”
BackgroundSelf-citationThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Self-citationHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Self-citationBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Self-citationA Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,153
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Self-citation
Cited by
Sorted by citations
Items 801–900 of 1,010
Daude, N., Kim, C., Kang, S., Eskandari‐Sedighi, G., Haldiman, T., Yang, J., Fleck, S. C., Gomez‐Cardona, E., Han, Z. Z., Borrego‐Écija, S., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02148-4 · Cited by 30
Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
Caligiore, D., Silvetti, M., D’Amelio, M., Puglisi‐Allegra, S., & Baldassarre, G. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200276 · Cited by 30
Venneri, A., & Marco, M. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-71368-1 · Cited by 30
Dünnwald, M., Ernst, P., Düzel, E., Tönnies, K. D., Betts, M. J., & Oeltze‐Jafra, S. (2021) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-021-02528-5 · Cited by 30
Bernaud, V. E., Bulen, H. L., Peña, V., Koebele, S. V., Northup-Smith, S. N., Manzo, A. A., Sanchez, M. V., Opachich, Z., Ruhland, A., & Bimonte‐Nelson, H. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-18415-1 · Cited by 30
Loftus, J. R., Puri, S., & Meyers, S. P. (2023) · Insights into Imaging · doi:10.1186/s13244-022-01358-6 · Cited by 30
Chronic Traumatic Encephalopathy and Neurodegeneration in Contact Sports and American Football
Zuckerman, S. L., Brett, B. L., Jeckell, A. S., Yengo-Kahn, A. M., & Solomon, G. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180218 · Cited by 30
Risk of Misdiagnosing Chronic Traumatic Encephalopathy in Men With Depression
Iverson, G. L., & Gardner, A. J. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19010021 · Cited by 30
Libard, S., & Alafuzoff, I. I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0748-9 · Cited by 29
Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
Rullmann, M., Brendel, M., Schroeter, M. L., Saur, D., Levin, J., Perneczky, R. G., Tiepolt, S., Patt, M., Mueller, A., Villemagne, V. L., et al. (2022) · Biomolecules · doi:10.3390/biom12030458 · Cited by 29
Galgani, A., & Giorgi, F. S. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01324-9 · Cited by 29
Regional vulnerability to lipoxidative damage and inflammation in normal human brain aging
Domínguez-González, M., Puigpinós, M., Jové, M., Naudí, A., Portero‐Otín, M., Pamplona, R., & Ferrer, I. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.023 · Cited by 29
Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model
Leboucher, A., Ahmed, T., Caron, É., Tailleux, A., Raison, S., Joly‐Amado, A., Marciniak, E., Carvalho, K., Hamdane, M., Bantubungi, K., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.008 · Cited by 29
Cellular Biology of Tau Diversity and Pathogenic Conformers
Kang, S., Eskandari‐Sedighi, G., Hromádková, L., Safar, J., & Westaway, D. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590199 · Cited by 29
Chiu, M., Yang, S., Chen, T., Lin, C., Yang, F., Chen, W., Zetterberg, H., & Blennow, K. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00010 · Cited by 29
Primary age‐related tauopathy in a Finnish population‐based study of the oldest old (Vantaa 85+)
Savola, S. E., Kaivola, K., Raunio, A., Kero, M., Mäkelä, M., Pärn, K., Palta, P., Tanskanen, M., Tuimala, J., Polvikoski, T. M., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12788 · Cited by 29
Matsuda, H., Okita, K., Motoi, Y., Mizuno, T., Ikeda, M., Sanjo, N., Murakami, K., Kambe, T., Takayama, T., Yamada, K., et al. (2022) · Annals of Nuclear Medicine · doi:10.1007/s12149-022-01792-y · Cited by 29
Pierouli, K., Papakonstantinou, E., Papageorgiou, L., Diakou, I., Mitsis, Τ., Dragoumani, K., Spandidos, D. A., Bacopoulou, F., Chrousos, G. P., Goulielmos, G. N., et al. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5208 · Cited by 29
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Jiang, Y., Lin, Y., Krishnaswamy, S., Pan, R., Wu, Q., Sandusky‐Beltran, L. A., Liu, M., Kuo, M., Kong, X., Congdon, E. E., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf3775 · Cited by 29
Bachman, S. L., Cole, S. W., Yoo, H. J., Nashiro, K., Min, J., Mercer, N., Nasseri, P., Thayer, J. F., Lehrer, P. M., & Mather, M. (2022) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2023.08.014 · Cited by 29
Gezen‐Ak, D., & Dursun, E. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230214 · Cited by 29
Nishida, N., Yoshida, K., Hata, Y., Arai, Y., & Kinoshita, K. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12229 · Cited by 29
Dordevic, M., Müller-Fotti, A., Müller, P., Schmicker, M., Kaufmann, J., & Müller, N. G. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170021 · Cited by 29
Initiative, A. D. N., Vuoksimaa, E., McEvoy, L. K., Holland, D., Franz, C. E., & Kremen, W. S. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-0019-6 · Cited by 29
Distinct Brain Regions in Physiological and Pathological Brain Aging
Lee, J. S., Park, Y. H., Park, S., Yoon, U., Choe, Y. S., Cheon, B. K., Hahn, A., Cho, S. H., Kim, S. J., Kim, J. P., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00147 · Cited by 29
Modulation of L-type calcium channels in Alzheimer’s disease: A potential therapeutic target
Crossley, C. A., Rajani, V., & Yuan, Q. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.049 · Cited by 28
Van Egroo, M., van Someren, E. J. W., Grinberg, L. T., Bennett, D. A., & Jacobs, H. I. L. (2024) · Annals of Neurology · doi:10.1002/ana.26880 · Cited by 28
Stone, D. B., Ryman, S. G., Hartman, A. P., Wertz, C. J., Vakhtin, A. A., & Initiative, A. D. N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.711579 · Cited by 28
Low prevalence of amyloid and tau pathology in drug-resistant temporal lobe epilepsy.
Silva, J. C., Vivash, L., Malpas, C. B., Hao, Y., McLean, C., Chen, Z., O'Brien, T. J., Jones, N. C., & Kwan, P. (2021) · Epilepsia · doi:10.1111/epi.17086 · Cited by 28
Hussain, R., Ashraf, M., Khan, S., Rahim, F., Rehman, W. U., Taha, M., Sardar, A., Khan, Y., Khan, I., & Shah, S. A. A. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136582 · Cited by 28
Autonomic dysfunction in neurodegenerative disease
Mather, M. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00911-8 · Cited by 28
Computed Tomography Assessment of Brain Atrophy in Centenarians
Chrzan, R. M., Gleń, A., Bryll, A., & Urbanik, A. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193659 · Cited by 28
Arenas, F., Castro, F., Núñez, S., Gay, G., García‐Ruiz, C., & Fernández-Checa, J. C. (2020) · Aging · doi:10.18632/aging.102641 · Cited by 28
Clement, A., Wiborg, O., & Asuni, A. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00056 · Cited by 28
Chronic Traumatic Encephalopathy and Neuropathological Comorbidities
Stein, T. D., & Crary, J. F. (2020) · Seminars in Neurology · doi:10.1055/s-0040-1713628 · Cited by 28
Levin, F., Jelistratova, I., Betthauser, T. J., Okonkwo, O. C., Johnson, S. C., Teipel, S. J., & Grothe, M. J. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00918-0 · Cited by 28
Tang, H., & Harte, M. (2021) · Genes · doi:10.3390/genes12111753 · Cited by 28
P62 accumulates through neuroanatomical circuits in response to tauopathy propagation
de Thé, F.-X. B., Lassus, B., Schaler, A. W., Fowler, S. L., Goulbourne, C. N., Jeggo, R., la Cour, C. M., Millan, M. J., & Duff, K. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01280-w · Cited by 28
Dawood, D. H., Srour, A. M., Omar, M. A., Farghaly, T. A., & El‐Shiekh, R. A. (2023) · Archiv der Pharmazie · doi:10.1002/ardp.202300201 · Cited by 28
Memory factors in Rey AVLT : Implications for early staging of cognitive decline
Fernaeus, S., Östberg, P., Wahlund, L., & Hellström, Å. (2014) · Scandinavian Journal of Psychology · doi:10.1111/sjop.12157 · Cited by 28
Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
Thal, D. R. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00025 · Cited by 28
Self-citationThe role of Plasma Membrane Calcium ATPases (PMCAs) in neurodegenerative disorders
Hajieva, P., Baeken, M. W., & Moosmann, B. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.033 · Cited by 28
Neurogenesis Makes a Crucial Contribution to the Neuropathology of Alzheimer’s Disease
Young, J. K. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200218 · Cited by 28
Speech patterns during memory recall relates to early tau burden across adulthood
Young, C. B., Smith, V., Karjadi, C., Grogan, S., Ang, T. F. A., Insel, P. S., Henderson, V. W., Sumner, M., Poston, K. L., Au, R., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13731 · Cited by 27
Sequence of proteome profiles in preclinical and symptomatic Alzheimer's disease
Li, X., Tsolis, K. C., Koper, M. J., Ronisz, A., Ospitalieri, S., von Arnim, C. A. F., Vandenberghe, R., Tousseyn, T., Scheuerle, A., Economou, A., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12345 · Cited by 27
Self-citationSackmann, C., & Hallbeck, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63398-6 · Cited by 27
Wearn, A. R., Tremblay, S. A., Tardif, C. L., Leppert, I. R., Gauthier, C. J., Baracchini, G., Hughes, C. S., Hewan, P., Tremblay‐Mercier, J., Rosa‐Neto, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48490-z · Cited by 27
Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer’s disease
Pierson, S. R., Fiock, K. L., Wang, R., Balasubramanian, N., Reinhardt, J., Khan, K. M., James, T. D., Hunter, M. L., Cooper, B. J., Williamsen, H. R., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02664-9 · Cited by 27
Kelliny, S., Zhou, X., & Bobrovskaya, L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70046 · Cited by 27
Tosun, D., Chen, Y.-F., Yu, P., Sundell, K. L., Suhy, J., Siemers, E., Schwarz, A. J., Weiner, M. W., & Initiative, A. D. N. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.03.009 · Cited by 27
Kok, E., Karppinen, T. T., Luoto, T. M., Alafuzoff, I. I., & Karhunen, P. J. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13102 · Cited by 27
Schymanski, E., Baker, N., Williams, A. J., Singh, R. R., Trezzi, J., Wilmes, P., Kolber, P. L., Krüger, R., Paczia, N., Linster, C. L., et al. (2019) · Environmental Science Processes & Impacts · doi:10.1039/c9em00068b · Cited by 27
Shaffer, R. M., Li, G., Adar, S. D., Keene, C. D., Latimer, C. S., Crane, P. K., Larson, E. B., Kaufman, J. D., Carone, M., & Sheppard, L. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201005 · Cited by 27
Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects
Giorgi, F. S., Lombardo, F. P., Galgani, A., Hlavata, H., Latta, D. D., Martini, N., Pavese, N., Ghicopulos, I., Baldacci, F., Coi, A., et al. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00562-0 · Cited by 27
Pillai, J. A., Bena, J., Rothenberg, K. G., Boron, B., & Leverenz, J. B. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0729 · Cited by 27
Phosphomimetics at Ser199/Ser202/Thr205 in Tau Impairs Axonal Transport in Rat Hippocampal Neurons
Christensen, K. R., Combs, B., Richards, C. J., Grabinski, T. M., Alhadidy, M. M., & Kanaan, N. M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03281-3 · Cited by 27
Chen, X., Toueg, T. N., Harrison, T. M., Baker, S. L., & Jagust, W. J. (2023) · Annals of Neurology · doi:10.1002/ana.26813 · Cited by 27
Ageing-Related Neurodegeneration and Cognitive Decline
Alafuzoff, I. I., & Libard, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074065 · Cited by 27
Daulatzai, M. A. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9643-3 · Cited by 27
Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies
Lund, H., Pieber, M., & Harris, R. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00234 · Cited by 27
Ferrer, I. (2018) · Neuroglia · doi:10.3390/neuroglia1010010 · Cited by 27
Neumann, U., Machauer, R., & Shimshek, D. R. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14582 · Cited by 27
Central autonomic network dysfunction and plasma Alzheimer’s disease biomarkers in older adults
Lohman, T., Kapoor, A., Engstrom, A. C., Shenasa, F., Alitin, J. P. M., Gaubert, A., Rodgers, K. E., Bradford, D. R., Mather, M., Han, S. D., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01486-9 · Cited by 26
Flynn, C. M., Omoluabi, T., Janes, A. M., Rodgers, E. J., Torraville, S. E., Negandhi, B. L., Nobel, T. E., Mayengbam, S., & Yuan, Q. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01674-1 · Cited by 26
Ohm, D. T., Peterson, C. S., Lobrovich, R., Cousins, K. A. Q., Gibbons, G. S., McMillan, C. T., Wolk, D. A., Deerlin, V. M. V., Elman, L. B., Spindler, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02210-1 · Cited by 26
Epigenetic Regulation of BMAL1 with Sleep Disturbances and Alzheimer’s Disease
Hulme, B., Didikoğlu, A., Bradburn, S., Robinson, A., Canal, M. M., Payton, A., Pendleton, N., & Murgatroyd, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200634 · Cited by 26
Sergott, R. C., Raji, A., Kost, J. T., Sur, C., Jackson, S., Locco, A., Patel, A., Furtek, C. I., Mattson, B. A., & Egan, M. F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200735 · Cited by 26
Biomarcadores en la enfermedad de Alzheimer
Janeiro, M. H., Ardanaz, C. G., Sola-Sevilla, N., Dong, J., Cortés-Erice, M., Solas, M., Puerta, E., & Ramírez, M. J. (2021) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0109 · Cited by 26
Sakakibara, Y., Hirota, Y., Ibaraki, K., Takei, K., Chikamatsu, S., Tsubokawa, Y., Saito, T., Saido, T. C., Sekiya, M., & Iijima, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210385 · Cited by 26
Photodynamic Alzheimer’s disease therapy: From molecular catalysis to photo-nanomedicine
Xu, Y., Xiong, H., Zhang, B., Lee, I., Xie, J., Li, M., Zhang, H., & Kim, J. S. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214726 · Cited by 26
Xiong, X., Hu, T., Yin, Z., Zhang, Y., Chen, F., & Lei, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.944283 · Cited by 26
van den Berg, M., Adhikari, M. H., Verschuuren, M., Pintelon, I., Vasilkovska, T., Audekerke, J. V., Missault, S., Heymans, L., Ponsaerts, P., Vos, W. H. D., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01089-2 · Cited by 26
The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals
Walker, J. M., Dehkordi, S. K., Schaffert, J., Goette, W. F., White, C. L., Richardson, T. E., & Zare, H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220898 · Cited by 26
Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease
Madsen, L. S., Parbo, P., Ismail, R., Gottrup, H., Østergaard, L., Brooks, D. J., & Eskildsen, S. F. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.12.006 · Cited by 26
Obesity during preclinical Alzheimer's disease development exacerbates brain metabolic decline
Anderson, T., Sharma, S. K., Kelberman, M. A., Ware, C. B., Guo, N., Qin, Z. S., Weinshenker, D., & Parent, M. B. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15900 · Cited by 26
Syed, A. U., Liang, C., Patel, K. K., Mondal, R., Kamalia, V. M., Moran, T. R., Ahmed, S. T., & Mukherjee, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310808 · Cited by 26
Khan, S., Hussain, R., Khan, Y., Iqbal, T., Darwish, H. W., & Ali, M. G. H. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.137417 · Cited by 26
Functional locus coeruleus imaging to investigate an ageing noradrenergic system
Ludwig, M., Yi, Y., Lüsebrink, F., Callaghan, M. F., Betts, M. J., Yakupov, R., Weiskopf, N., Dolan, R. J., Düzel, E., & Hämmerer, D. (2024) · Communications Biology · doi:10.1038/s42003-024-06446-5 · Cited by 26
Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer Disease
Al‐Dahhak, R., Khoury, R., Qazi, E., & Grossberg, G. T. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2018.06.008 · Cited by 26
Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease
Yu, C.-C., Jiang, T., Yang, A., Du, Y., Wu, M., & Kong, L.-H. (2019) · Neural Plasticity · doi:10.1155/2019/6856327 · Cited by 26
Fertan, E., Wong, A. A., Vienneau, N. A., & Brown, R. E. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111937 · Cited by 26
Taylor, M. E., & Close, J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63916-5.00019-7 · Cited by 26
Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
Kadamangudi, S., Marcatti, M., Zhang, W.-R., Fracassi, A., Kayed, R., Limon, A., & Taglialatela, G. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02839-2 · Cited by 25
Zinc utilization by microglia in Alzheimer’s disease
Shippy, D. C., Oliai, S. F., & Ulland, T. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107306 · Cited by 25
Martin, S. C., Joyce, K. K., Lord, J. S., Harper, K. M., Nikolova, V. D., Cohen, T. J., Moy, S. S., & Diering, G. H. (2024) · eNeuro · doi:10.1523/eneuro.0004-24.2024 · Cited by 25
Richardson, T. E., Walker, J. M., Farrell, K. W., Oliveira, T. G., White, C. L., & Crary, J. F. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02943-x · Cited by 25
Age-Related Changes in Speech Understanding: Peripheral Versus Cognitive Influences
Gordon-Salant, S. M., Shader, M. J., & Wingfield, A. (2020) · Springer handbook of auditory research · doi:10.1007/978-3-030-49367-7_9 · Cited by 25
The Significance of Tau Aggregates in the Human Brain
Castellani, R. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120972 · Cited by 25
Evans, A. K., Park, H. H., Saw, N. L., Singhal, K., Ogawa, G., Leib, R. D., & Shamloo, M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.012 · Cited by 25
Associations between MRI-assessed locus coeruleus integrity and cortical gray matter microstructure
Elman, J. A., Puckett, O. K., Hagler, D. J., Pearce, R. C., Fennema‐Notestine, C., Hatton, S. N., Lyons, M. J., McEvoy, L. K., Panizzon, M. S., Reas, E. T., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab475 · Cited by 25
Astrocytic C–X–C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity
Perez‐Nievas, B. G., Johnson, L., Beltran-Lobo, P., Hughes, M. M., Gammallieri, L., Tarsitano, F., Myszczynska, M. A., Vázquez-Villaseñor, I., Jiménez-Sánchez, M., Troakes, C., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02371-0 · Cited by 25
Carvalho, D. Z., Louis, E. K. S., Przybelski, S. A., Morgenthaler, T. I., Machulda, M. M., Boeve, B. F., Petersen, R. C., Jack, C. R., Graff‐Radford, J., Vemuri, P., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.930315 · Cited by 25
Aβ Deposits in the Neocortex of Adult and Infant Hypoxic Brains, Including in Cases of COVID-19
Priemer, D. S., Rhodes, C. H., Karlovich, E., Perl, D. P., & Goldman, J. E. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac095 · Cited by 25
Kleineidam, L., Wolfsgruber, S., Weyrauch, A., Zulka, L. E., Forstmeier, S., Roeske, S., van den Bussche, H., Kaduszkiewicz, H., Wiese, B., Weyerer, S. B., et al. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.957308 · Cited by 25
Sharma, P., & Singh, M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121568 · Cited by 25
Yamazaki, Y., Suwabe, K., Nagano‐Saito, A., Saotome, K., Kuwamizu, R., Hiraga, T., Torma, F., Suzuki, K., Sankai, Y., Yassa, M. A., et al. (2023) · Cerebral Cortex Communications · doi:10.1093/texcom/tgad010 · Cited by 25
Maggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Comparative Incidence of Conformational, Neurodegenerative Disorders
de Pedro‐Cuesta, J., Rábano, A., Martínez‐Martín, P., Ruiz-Tovar, M., Alcalde-Cabero, E., Almazán‐Isla, J., Avellanal, F., & Calero, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137342 · Cited by 25
Jembrek, M. J., Leko, M. B., Pivac, N., Hof, P. R., & Šimić, G. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0144-z · Cited by 25
Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects
Caballero, M. Á. A., Brendel, M., Delker, A., Ren, J., Rominger, A., Bartenstein, P., Dichgans, M., Weiner, M. W., & Ewers, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.007 · Cited by 25
Metadata
- Authors
- Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Braak, Heiko
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-11
- Volume
- 70
- Issue
- 11
- Pages
- 960-969
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1993023011
- Cited by
- 2,194
- References
- 75
- Citations by year
- 2026: 152 · 2025: 192 · 2024: 260 · 2023: 233 · 2022: 192 · 2021: 235 · 2020: 182 · 2019: 144 · 2018: 121 · 2017: 110 · 2016: 100 · 2015: 85 · 2014: 78 · 2013: 65 · 2012: 42
- FWCI
- 41.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer Forschung Initiative (10810)
- Deutsche Forschungsgemeinschaft (TH624 4–1)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, pathological staging, tauopathy, neurofibrillary tangles, amyloid plaques, locus coeruleus, brainstem, sporadic Alzheimer's disease, AT8 antibody
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Neurons, Cohort Studies, Amyloid beta-Peptides, Silver Staining, Neurofibrillary Tangles, tau Proteins, Disease Progression, Statistics, Nonparametric, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
